Aurora Cannabis has been a disappointing investment, but the business has been showing improvement lately. The company expects to generate positive free cash flow next year, and it is profitable on an ...

Forbes contributors publish independent expert analyses and insights. Dario Sabaghi covers the cannabis industry with a focus on Europe. Aurora Cannabis is facing a class action led by a Canadian ...

The medical cannabis segment offers higher margins, compared to its recreational counterpart. To wit, Aurora's adjusted gross margins for medical cannabis have consistently hit or exceeded the company ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

It wasn't all that long ago that pot producer Aurora Cannabis (NASDAQ: ACB) was a leading company in the cannabis industry. Its sales growth was strong and the company was expanding its operations.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Compared to the ailing business it was in the past, the Aurora Cannabis (NASDAQ: ACB) of today is making strategic moves, and it's also operating a lot more efficiently. With a bit more in the way of ...

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, ...